Profile data is unavailable for this security.
About the company
Molina Healthcare, Inc. is a provider of managed healthcare services under the medicaid and medicare programs, and through the state insurance marketplaces. The Company operates through four segments: Medicaid, Medicare, Marketplace and Other. The Medicaid, Medicare, and Marketplace segments represent the government-funded or sponsored programs under which it offers managed healthcare services. Medicaid provides healthcare and long-term services and support to low-income Americans. Medicare is a federal program that provides eligible persons aged 65 and over, and some disabled persons, with a variety of hospital, medical insurance, and prescription drug benefits. The Marketplace insurance exchanges allow individuals and small groups to purchase federally subsidized health insurance. It arranges healthcare services for its members through contracts with a network of providers, including independent physicians and physician groups, hospitals, ancillary providers, and pharmacies.
- Revenue in USD (TTM)39.20bn
- Net income in USD1.14bn
- Incorporated2002
- Employees18.00k
- LocationMolina Healthcare Inc200 Oceangate, Suite 100LONG BEACH 90802-4317United StatesUSA
- Phone+1 (562) 435-3666
- Fax+1 (302) 636-5454
- Websitehttps://www.molinahealthcare.com/
Mergers & acquisitions
Acquired company | MOH:NYQ since announced | Transaction value |
---|---|---|
ConnectiCare Holding Co | 0.41% | 350.00m |
Peer analysis
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Ensign Group Inc | 4.11bn | 239.98m | 8.39bn | 35.30k | 35.43 | 4.80 | 26.09 | 2.04 | 4.13 | 4.13 | 70.86 | 30.50 | 0.9433 | -- | 8.01 | 116,391.30 | 5.52 | 6.45 | 6.63 | 7.88 | 21.19 | 22.32 | 5.85 | 6.48 | -- | -- | 0.0773 | 6.56 | 23.27 | 16.28 | -6.80 | 28.62 | 4.40 | 5.02 |
Chemed Corp | 2.38bn | 301.73m | 8.55bn | 15.09k | 28.86 | 6.90 | 23.47 | 3.60 | 19.78 | 19.78 | 155.82 | 82.78 | 1.43 | 136.49 | 13.04 | 157,566.50 | 18.11 | 19.53 | 21.79 | 24.64 | 35.66 | 34.60 | 12.69 | 12.60 | 1.81 | -- | 0.00 | 8.15 | 6.06 | 4.90 | 9.17 | 5.80 | 1.46 | 6.10 |
Encompass Health Corp | 5.22bn | 431.20m | 10.19bn | 22.36k | 23.93 | 5.20 | 11.92 | 1.95 | 4.23 | 4.11 | 51.10 | 19.45 | 0.8396 | -- | 9.38 | 233,270.70 | 9.07 | 6.37 | 11.87 | 7.94 | 95.49 | 95.58 | 10.80 | 9.16 | -- | 6.14 | 0.486 | 30.78 | 10.41 | 2.34 | 41.31 | 4.49 | 16.60 | -10.42 |
Universal Health Services, Inc. | 15.42bn | 1.03bn | 13.07bn | 73.35k | 13.17 | 1.98 | 8.02 | 0.8478 | 15.03 | 15.03 | 225.85 | 100.14 | 1.09 | -- | 6.93 | 210,194.40 | 7.41 | 6.44 | 8.68 | 7.63 | -- | -- | 6.78 | 6.55 | 1.28 | 7.70 | 0.4105 | 6.06 | 6.59 | 5.80 | 6.32 | -1.47 | 1.17 | 14.87 |
Davita Inc | 12.67bn | 827.68m | 13.57bn | 70.00k | 17.84 | 35.36 | 7.23 | 1.07 | 9.28 | 9.28 | 141.50 | 4.68 | 0.7357 | 71.34 | 5.90 | 180,951.60 | 6.58 | 5.62 | 8.88 | 7.45 | 32.80 | 30.70 | 8.94 | 8.33 | 1.33 | 4.77 | 0.8115 | -- | 4.57 | 1.26 | 26.44 | 2.33 | -10.47 | -- |
Tenet Healthcare Corp | 20.97bn | 3.13bn | 13.66bn | 78.14k | 4.59 | 3.56 | 2.85 | 0.6513 | 31.26 | 31.26 | 209.81 | 40.32 | 0.7364 | 9.49 | 7.15 | 268,376.30 | 13.86 | 3.61 | 20.23 | 5.09 | 82.61 | 82.97 | 18.83 | 4.95 | 1.52 | 5.37 | 0.6145 | 0.00 | 7.17 | 2.33 | 49.02 | 41.42 | 4.01 | -- |
Molina Healthcare Inc | 39.20bn | 1.14bn | 16.63bn | 18.00k | 14.76 | 3.47 | 12.55 | 0.4243 | 19.70 | 19.70 | 674.97 | 83.68 | 2.56 | -- | 13.71 | 2,177,722.00 | 7.47 | 7.62 | 16.58 | 16.80 | 16.12 | 15.99 | 2.92 | 3.04 | -- | 14.83 | 0.3465 | 0.00 | 6.56 | 12.52 | 37.75 | 9.06 | 22.87 | -- |
Quest Diagnostics Inc | 9.54bn | 838.00m | 18.26bn | 40.00k | 21.96 | 2.69 | 13.68 | 1.91 | 7.45 | 7.45 | 84.79 | 60.79 | 0.645 | 34.77 | 7.18 | 238,475.00 | 5.87 | 9.28 | 6.77 | 10.81 | 32.94 | 36.64 | 9.10 | 12.97 | 1.17 | 8.87 | 0.4746 | 25.07 | -6.38 | 4.20 | -9.77 | 3.40 | 1.27 | 7.43 |
Labcorp Holdings Inc | 12.71bn | 435.50m | 20.05bn | 67.00k | 46.45 | 2.46 | 18.98 | 1.58 | 5.16 | 5.16 | 150.40 | 97.61 | 0.7162 | 19.41 | 5.93 | 189,743.30 | 2.46 | 6.27 | 3.00 | 7.37 | 27.92 | 32.33 | 3.44 | 9.51 | 1.30 | 5.59 | 0.455 | -- | 2.51 | 1.42 | -62.16 | -16.40 | 3.62 | -- |
Natera Inc | 1.53bn | -214.69m | 20.69bn | 3.28k | -- | 23.63 | -- | 13.50 | -1.77 | -1.77 | 12.59 | 7.08 | 1.01 | 14.29 | 5.45 | 466,774.80 | -14.14 | -36.17 | -17.55 | -46.60 | 57.66 | 45.88 | -14.01 | -56.15 | 4.23 | -- | 0.2947 | -- | 31.99 | 33.26 | 20.63 | -- | 58.81 | -- |
Holder | Shares | % Held |
---|---|---|
The Vanguard Group, Inc.as of 30 Sep 2024 | 6.40m | 11.19% |
Capital Research & Management Co. (World Investors)as of 30 Sep 2024 | 5.13m | 8.97% |
T. Rowe Price Associates, Inc. (IM)as of 30 Sep 2024 | 3.86m | 6.74% |
BlackRock Fund Advisorsas of 30 Sep 2024 | 3.55m | 6.21% |
Capital Research & Management Co. (Global Investors)as of 30 Sep 2024 | 3.49m | 6.10% |
SSgA Funds Management, Inc.as of 30 Sep 2024 | 2.61m | 4.57% |
T. Rowe Price Investment Management, Inc.as of 30 Sep 2024 | 2.01m | 3.51% |
Wellington Management Co. LLPas of 30 Sep 2024 | 1.96m | 3.44% |
Capital Research & Management Co. (International Investors)as of 30 Sep 2024 | 1.71m | 3.00% |
Geode Capital Management LLCas of 30 Sep 2024 | 1.40m | 2.45% |